Table 2.
Groups | Mucosal thickness (mm) x̄ ± SD |
Villus length (mm) x̄ ± SD |
Villus length/crypt ratio x̄ ± SD |
SQHE Total result x̄ ± SD |
MTX (n=10) | 0.17±0.05a | 0.21±0.07a | 2.33±0.55a | 22.67±4.44a |
RJ50+MTX(n=11) | 0.29±0.09ab | 0.20±0.17a | 3.16±1.99ab | 10.70±0.05b |
RJ100+MTX (n=12) | 0.37±0.10b | 0.19±0.05a | 3.41±0.9b | 14.8±5.10b |
RJ 50 (n=12) | 0.41±0.10b | 0.35±0.62b | 5.40±0.08c | 4.33±2.81c |
RJ 100 (n=12) | 0.47±0.13b | 0.34±0.06b | 4.79±1.44cd | 3.00±1.55c |
Control (n=12) | 0.42±0.15b | 0.40±0.82b | 4.39±0.89d | 2.83±1.474c |
P | <0.05 | <0.001 | <0.05 | <0.001 |
MTX; Methotrexate, RJ; Royal Jelly, x̄ ± SD; mean ± standard deviation, SQHE; Semi-quantitative histological evaluation, Alphabetical superscripts; same letters indicate the absence of statistical significance between the groups, means that they are similar; different letters indicate the presence of statistically significant difference between the groups, means that they are distinct.